by Nancy Roach DANIEL-SARGENT-150x150We're incredibly saddened about the passing of Dr. Dan Sargent, a member of our Medical Advisory Board. Dan’s work touched the lives of everyone diagnosed with colorectal cancer – he worked on individual trials and also was involved with updating staging information. He generously led a patient webinar for us in 2012 recapping the GI Cancer Symposium. His work in stage III cancer showed that Folfox actually saved lives, and he led an ongoing international collaboration that will answer the question of three months versus six months of Folfox. He’s one of the most respected researchers I know. He always focused on the patient benefit and was willing to do the hard work. He’s one of the first researchers who helped us learn what we needed to know to be effective patient advocates. He wanted to see us work together and increase our impact for patients.  I have a deep level of respect for him, and his unexpected passing is a huge loss for us all.